Skip to main content
. 2017 Jun 23;22:70–73. doi: 10.1016/j.rmcr.2017.06.012

Table 1.

Characteristics of patients diagnosed with Mycobacterium avium complex pulmonary disease following treatment for lung cancer.

Subject, No. (%)
Demographics
 Male Sex 4 (30.8)
 Age, years
 Mean 69.8
 Range 48–82
MAC Pulmonary Involvement
 Non-cavitary 7 (53.8)
 Cavitary 6 (46.2)
Underlying Pulmonary Disease
 COPD 6 (46.2)a,b
 Bronchiectasis 3 (23.1)a,c
 None 5 (38.5)d
Pulmonary Cancer Type
 Adenocarcinoma 8 (61.5)e
 SCC 3 (23.1)
 Carcinoid 3 (23.1)e
Cancer Treatment
 Systemic Chemotherapy 5 (38.5)
 Targeted Radiation 5 (38.5)
 Surgical Resection 10 (76.9)

Abbreviations: COPD=Chronic obstructive Pulmonary Disease, SCC = Squamous cell carcinoma, MAC = Mycobacterium avium complex.

a

One patient had both COPD and bronchiectasis.

b

One patient with COPD was also treated with etanercept prior to the diagnosis of MAC pulmonary disease.

c

One patient with bronchiectasis was diagnosed with lymphoma soon after diagnosis of MAC pulmonary disease.

d

One patient without underlying pulmonary disease was also treated with everolimus for metastatic renal cell carcinoma.

e

One patient was diagnosed with both pulmonary adenocarcinoma and pulmonary carcinoid.